Medpace Holdings Inc. Faces Securities Fraud Lawsuit; Investors May Seek Lead Plaintiff Status
Medpace Holdings Inc. (NASDAQ: MEDP) is involved in a securities fraud lawsuit, with investors who purchased shares between April 22, 2025, and February 9, 2026, potentially eligible to become lead plaintiffs. The stock price dropped by over 15.9% following allegations of concealed backlog cancellation issues. The deadline for filing a motion to be appointed as lead plaintiff is June 8, 2026.
Tickers: $MEDP
Topics: class action lead plaintiff PSLRA securities litigation stock loss